T Jeffrey Dunn

Title: Innovations of T Jeffrey Dunn

Introduction

T Jeffrey Dunn is a notable inventor based in Cedar Hill, MO (US), recognized for his contributions to the field of peptide synthesis. With a total of 7 patents to his name, Dunn has made significant advancements in the incorporation of ligand precursors into peptides.

Latest Patents

His latest patents focus on compositions and methods for incorporating ligand precursors and ligands at any location within a peptide during peptide synthesis. Specifically, he has developed methods for the selective incorporation of derivatives of 2,4,5-triaminopentanoic acid and γ-aminoglutamic acid into peptides during both solid phase and liquid phase synthesis. The choice of protecting groups plays a crucial role in this process. Furthermore, ligand synthesis can be completed at a later time to produce various chelating agents, including N3S, N2S2, and EDTA type agents.

Career Highlights

Throughout his career, Dunn has worked with prominent companies, including Mallinckrodt Medical, Inc. His work has significantly impacted the field of medical and biochemical research, particularly in the development of innovative peptide synthesis techniques.

Collaborations

Dunn has collaborated with notable professionals in his field, including Steven R Woulfe and Ananthachari Srinivasan. These collaborations have further enhanced his research and development efforts.

Conclusion

T Jeffrey Dunn's innovative work in peptide synthesis and ligand incorporation has established him as a key figure in his field. His patents reflect a commitment to advancing scientific knowledge and practical applications in biochemistry.